Wefa Boughrara

3PUBLICATIONS
7CO-AUTHORS
Major global burdens of diseasePharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 15, 2025
ABCB1 c.3435 C > T (rs1045642) as a biomarker for carbamazepine efficacy and toxicity in Algerian patients with epilepsy: initial findings report.

Rachda Riffi, Wefa Boughrara, Meriem Samia Aberkane

|Jun 11, 2024
Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms.

Rachda Riffi, Wefa Boughrara, Amina Chentouf

|Mar 24, 2022
The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review.

Wefa Boughrara, Amina Chentouf

Pageof 1

Frequent Collaborators

3 joint publications

Amina Chentouf

2 joint publications

Rachda Riffi

2 joint publications

Wassila Ilias

2 joint publications

Amel Alioua Berrebbah